Myasthenia Gravis Clinical Trials Myasthenia Gravis RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Evaluating Long-term Safety of Efgartigimod Administered Intravenously in Children With Generalized Myasthenia Gravis
Condition:   Generalized Myasthenia Gravis Intervention:   Biological: Efgartigimod IV Sponsor:   argenx Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 16, 2022 Category: Research Source Type: clinical trials